Iowa veteran battles through illness on Appalachian Trail journey
Over the weekend, VanVelzen was at a veteran support stay in Glasgow, Virginia, recovering from Norovirus. He called it a 'minor setback' and is already back on the trail.
Earning his trail name 'Unicorn,' this mythical creature has covered a lot of ground even through a couple of health challenges, proving his physical strength and mental toughness.
The Caitlin Clark Effect: About 3 in 10 US adults follow women's sports, new poll finds
Last week, VanVelzen posted on his Facebook page that he had to make a stop at the VA Hospital in the Salem/Roanoke area of Virginia so doctors could check out a spider bite. After that was taken care of, he was back to hiking and taking lots of photos of the nature and beautiful scenery.
VanVelzen has less than 1,400 miles to go until the end of the trail in Maine. He hopes to get there by the last week of August.
If you'd like to follow along, follow his Facebook page: On the Appalachian Trail with Joedy
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
8 minutes ago
- Business Wire
Rhythm Express Named by Inc. Magazine as One of the Fastest Growing Private Firms in America
MINNEAPOLIS--(BUSINESS WIRE)-- VivaQuant, Inc. d.b.a. Rhythm Express, a leader in remote cardiac monitoring and digital health solutions, has been recognized as one of the fastest-growing private companies in the United States by Inc. Magazine for the third consecutive year, ranking #331. VivaQuant's continued recognition reflects the company's momentum in reshaping the future of cardiac care through intelligent remote monitoring technologies. 'We are proud of the accomplishments of our team. This is a tremendous honor to make this prestigious list for the third consecutive year. It's a powerful validation of the work we're doing to make cardiac care more accessible, efficient and effective,' said Brian Brockway, CEO of VivaQuant. 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day. We're proud to be driving meaningful change in patient outcomes through our Rhythm Express business and cutting-edge monitoring technologies.' 'This milestone belongs to our entire team and the providers and patients who trust our solutions every day.' — Brian Brockway, CEO Share Innovating the Future of Remote Cardiac Monitoring VivaQuant's flagship offering, Rhythm Express, delivers advanced, near-real time cardiac diagnostics via the small, one-piece, cellular enabled RX-1 mini ™ wearable device and Rhythm Access Portal™. The platform is designed to meet the growing demand for accurate, scalable and user-friendly remote cardiac monitoring services. With a continued focus on innovation and clinical excellence, VivaQuant is well-positioned to lead the next generation of digital cardiovascular care. About VivaQuant, Inc. VivaQuant, Inc. is a digital health company specializing in remote cardiac monitoring and diagnostic services. Through its Rhythm Express platform, VivaQuant combines cutting-edge wearable technology, enhanced proprietary noise removal & analytics, and clinical insight to support better outcomes for patients and providers nationwide.
Business Wire
8 minutes ago
- Business Wire
Wenzel Spine Announces Limited U.S. Commercial Launch and First Cases of its Expandable panaSIa™ SI Fusion System
AUSTIN, Texas--(BUSINESS WIRE)--Wenzel Spine, Inc., a medical device company pioneering minimally invasive surgical and analytic solutions for spinal disorders, today announced completion of first cases and the U.S. limited commercial launch of its novel panaSIa™ Expandable SI Fusion System. panaSIa is the first expandable sacroiliac (SI) fusion implant cleared by the FDA and represents a major breakthrough in addressing sacroiliac joint dysfunction with enhanced biomechanical stability and procedural efficiency. Designed to be implanted using a posterior, minimally invasive technique, panaSIa provides joint fixation through controlled expansion across the ilium and sacrum, offering immediate mechanical stability while preserving surrounding tissue. The implant's integrated graft chamber allows for post-expansion bone grafting without disengaging instrumentation, facilitating optimal fusion conditions and minimizing procedural complexity. The first U.S. procedures are part of a limited commercial release taking place at select surgical centers ahead of full launch in Q4 2025. 'panaSIa is unlike any SI fusion device currently available,' said Aaron Calodney, MD, a nationally recognized leader in interventional pain medicine. 'The implant expands to eliminate micro-motion, providing immediate stabilization. By slightly distracting the joint space, it may reduce pain by removing contact between the arthritic surfaces. It's simple, elegant, and biomechanically sound—a truly next-generation solution for SI joint fusion.' The panaSIa system expands Wenzel Spine's portfolio of stand-alone expandable fusion technologies and reflects the company's long-term commitment to minimally invasive innovation and surgeon-driven design. 'This launch is a defining milestone for Wenzel Spine,' said William Wilson, CEO of Wenzel Spine. 'Our team has spent nearly two decades perfecting expandable device design, and panaSIa brings that legacy to a new clinical segment. We are proud to offer providers a differentiated, minimally invasive solution that transforms SI joint fusion with precision, control, and speed.' About panaSIa™ SI Fusion System The panaSIa SI Fusion System is a posteriorly placed, expandable implant that transfixes the ilium and sacrum to immobilize the SI joint and promote fusion. It is offered in two sizes allowing for anatomical customization, while its streamlined instrumentation enables true MIS placement. The integrated expansion mechanism and post-expansion graft delivery system simplify the workflow and reduce operative time. panaSIa is available now in limited release and will be widely available in Q4 2025. About Wenzel Spine, Inc. Headquartered in Austin, Texas, Wenzel Spine, Inc. is a privately held medical technology company committed to advancing the standard of care for spinal disorders through minimally invasive surgical innovation and data-driven solutions. Wenzel Spine's technologies are used by leading spine and pain physicians across the country to streamline surgical procedures and improve patient outcomes. To learn more, visit:
Business Insider
9 minutes ago
- Business Insider
I had a double mastectomy at 26. I struggled with my new body and people's insensitive 'boob job' jokes.
Two days before my 26th birthday, cancer was the furthest thing from my mind until a phone call from my sister changed everything. At 31, and just three weeks postpartum, she had been diagnosed with stage 3C breast cancer. Genetic testing revealed she carried the BRCA1 mutation, which gives women up to an 87% lifetime risk of developing breast cancer. I got tested next, and I had the mutation too. Suddenly, I saw my breasts as a ticking time bomb. The choice I never thought I'd have to make I had two options: monitor closely with regular screenings and hope for early detection, or have a preventive double mastectomy. It felt like no real choice at all, and the decision wasn't easy. I'd always imagined breastfeeding my future children. I wasn't even close to starting a family. After meeting with surgeons, I opted for the mastectomy with implant reconstruction using cadaver skin. It had the shortest recovery time, but it was still a massive surgery. I was overwhelmed by the options and the gravity of what I was about to do. The comments I received didn't help. Some asked, "How big are you going to go?" It felt invasive and disheartening, as if people were more focused on my aesthetics than the life-saving reason behind the surgery and how scared I was for it. My operation took eight hours and left me with diagonal scars across each "mound," as my surgeon called them. I chose to remove my nipples, too; they're made of breast tissue, and I didn't want to leave any cancer risk behind. The physical aftermath was brutal. My pectoral muscles were cut and repositioned; I couldn't even hold my phone. I had to use my chin to pump soap. I had expanders placed to slowly stretch my skin for nine months before getting implants. Each saline injection was painful, sometimes causing intense spasms that sent me back to the hospital. Public reaction was strange The expanders were disfiguring, hard as rocks, and nothing like real breasts. Even though people knew I was having a mastectomy, many tried to lighten the mood with jokes comparing it to a " boob job." Their comments weren't malicious, just painfully unaware of the difference between elective enhancement procedures and a medically necessary, painful amputation and reconstruction. I felt minimized, misunderstood — like my experience was trivialized. Then, there was a seemingly insignificant interaction that changed everything for me. A self-conscious woman at the pool bravely and nervously asked if my breasts were real. For once, someone couldn't tell I was "different." I smiled and told her the truth. She looked relieved and thanked me for being so open. That moment sparked something in me. Perhaps being more proactively transparent could help others feel seen as well. I continued sharing my experience I had already been sharing my journey on Facebook, but I continued to open up, both online and offline, about the good, the bad, and the painful. I talked about genetic testing, reconstruction setbacks, and how awkward people can be when they don't know what to say. I often would joke about how you could bounce a quarter off my expanders ("but please don't because it hurts!"). The more I shared, the more comfortable I became in my new body. I found strength in the scars, humor in the awkwardness, and connection in the vulnerability. One day, a former college roommate reached out. After following my posts, she inquired about her family history and underwent testing. She and two other women in her family were positive for a similar mutation. My story helped her. When I first looked at my post-op body, I felt disconnected, disgusted, and self-conscious. Now, despite bright scars, numb patches, and misshapen "mounds," I'm overcome with gratitude when I see myself. My risk for breast cancer isn't zero, but it's significantly reduced. And every day I get to rock and sing with my two kids at night, something I hope to do for a long time.
